ClinicalTrials.Veeva

Menu

The Effect of Different Deproteinizing Agents on the Clinical Success of Fissure Sealants in Primary Teeth

T

Tokat Gaziosmanpasa University

Status

Enrolling

Conditions

Fissure Sealant

Treatments

Other: application of deproteinization agents

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Investigation of the effect of deproteinization agents on the clinical success of non-invasive fissure sealant application, which is a non-invasive method used to prevent caries formation or to stop the progression of initial caries lesions limited to enamel on tooth surfaces thought to be at high risk of caries.

Enrollment

60 estimated patients

Sex

All

Ages

4 to 6 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients between the ages of 4-6 who do not have any systemic problems
  • Have a score of 3 and 4 on the Frankl Behavior Scale
  • Do not have a habit of clenching and/or grinding their teeth
  • Have lower second primary molars without caries
  • Have an indication for fissure sealant application

Exclusion criteria

  • Teeth with fissure sealants
  • Teeth with developmental defects such as hypoplasia
  • Teeth with approximal or incipient caries lesions on one or both mandibular second primary molars

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Sodium Hypochlorite, Wizard
Active Comparator group
Description:
There are many studies in the literature showing that the use of 5.25% NaOCl as an enamel deproteinization agent is successful in positively affecting adhesion by removing organic elements from both the enamel structure and the pellicle on the enamel surface before acid application. However, sodium hypochlorite is a strong oxidizing agent and has disadvantages such as the risk of reaction in the soft tissues of the mouth, bad odor and bad taste, especially if not used carefully in pediatric dentistry, which has led to the search for an alternative material.
Treatment:
Other: application of deproteinization agents
Hypochlorous Acid, Superox
Experimental group
Description:
Hypochlorous acid is produced by the body's immune system cells, neutrophilic polymorphonuclear leukocytes, as a result of oxidative reactions to overcome pathogenic microorganisms and fight infection. Recently, slightly acidic HOCl solutions, developed by electrolysis of NaOCl, have been widely used as disinfectants. Hypochlorous acid has been shown to significantly reduce the lipopolysaccharide concentration of Porphyromonas gingivalis compared to NaOCl and chlorhexidine and to be an agent tolerated by oral tissues. It has also been reported that HOCl used as a mouthwash does not produce any systemic side effects. In clinical dentistry, HOCl has been shown to be highly effective as a result of its antimicrobial and deproteinizing properties. HOCl, with its low acidity, is an antiseptic irrigant with extraordinary properties, not only exhibiting biocompatibility and low cytotoxicity, but also having rapid and highly effective antimicrobial activity in physiological concentration ran
Treatment:
Other: application of deproteinization agents

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

alem coşgun

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems